1. Home
  2. LASE vs FBIOP Comparison

LASE vs FBIOP Comparison

Compare LASE & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASE
  • FBIOP
  • Stock Information
  • Founded
  • LASE 2019
  • FBIOP N/A
  • Country
  • LASE United States
  • FBIOP United States
  • Employees
  • LASE N/A
  • FBIOP 186
  • Industry
  • LASE Industrial Machinery/Components
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASE Industrials
  • FBIOP Health Care
  • Exchange
  • LASE Nasdaq
  • FBIOP Nasdaq
  • Market Cap
  • LASE N/A
  • FBIOP N/A
  • IPO Year
  • LASE 2022
  • FBIOP N/A
  • Fundamental
  • Price
  • LASE $5.05
  • FBIOP $5.10
  • Analyst Decision
  • LASE
  • FBIOP
  • Analyst Count
  • LASE 0
  • FBIOP 0
  • Target Price
  • LASE N/A
  • FBIOP N/A
  • AVG Volume (30 Days)
  • LASE 646.2K
  • FBIOP N/A
  • Earning Date
  • LASE 11-14-2024
  • FBIOP N/A
  • Dividend Yield
  • LASE N/A
  • FBIOP N/A
  • EPS Growth
  • LASE N/A
  • FBIOP N/A
  • EPS
  • LASE N/A
  • FBIOP N/A
  • Revenue
  • LASE $3,664,268.00
  • FBIOP N/A
  • Revenue This Year
  • LASE N/A
  • FBIOP N/A
  • Revenue Next Year
  • LASE N/A
  • FBIOP N/A
  • P/E Ratio
  • LASE N/A
  • FBIOP N/A
  • Revenue Growth
  • LASE 23.34
  • FBIOP N/A
  • 52 Week Low
  • LASE $0.67
  • FBIOP N/A
  • 52 Week High
  • LASE $19.80
  • FBIOP N/A
  • Technical
  • Relative Strength Index (RSI)
  • LASE 41.68
  • FBIOP 38.27
  • Support Level
  • LASE $4.81
  • FBIOP $5.00
  • Resistance Level
  • LASE $5.57
  • FBIOP $5.50
  • Average True Range (ATR)
  • LASE 0.49
  • FBIOP 0.46
  • MACD
  • LASE 0.08
  • FBIOP -0.05
  • Stochastic Oscillator
  • LASE 34.43
  • FBIOP 6.84

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Share on Social Networks: